The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials. Author(s): Rid A, Lipsitch M, Miller FG|Journal: JAMA|PMID: 33315080| December 2020 As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic continues to rage, developing safe and effective vaccines is critically…
Choices in vaccine trial design in epidemics of emerging infections. Author(s): Kahn R, Rid A, Smith PG, Eyal N, Lipsitch M|Journal: PLoS Med|PMID: 30086139| August 2018 In a Policy Forum, Marc Lipsitch and colleagues discuss trial design issues in infectious disease outbreaks.
